{"disease":{"id":"condylomata-acuminata","name":"condylomata acuminata"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04537156","title":"Efficacy, Immunogenicity and Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":9327,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT00090285","title":"An Investigational Study of Gardasil™ (qHPV Vaccine) in Reducing the Incidence of Anogenital Warts in Young Men (V501-020)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":4065,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT05056402","title":"An Immuno-bridging Study of a Nonavalent HPV Vaccine (E.Coli) in Healthy Population Aged 9-17 vs Aged 18-26 Years Old","phase":"PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":1382,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT02710851","title":"Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":640,"lead_sponsor_name":"Jun Zhang","has_results":false},{"nct_id":"NCT03935204","title":"Immunogenicity Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":627,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT04782895","title":"Immunogenicity of a Recombinant Human Papillomavirus Nonavalent (Types 6,11,16,18,31,33,45,52,58)Vaccine(E.Coli) Versus Gardasil®9 in Healthy Females 18-26 Years of Age","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":488,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT06197802","title":"Plateau Antibody Levels of a Recombinant (E.Coli) HPV Nonavalent Vaccine Versus Gardasil®9 in Young Women","phase":"","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":392,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT03546842","title":"Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":201,"lead_sponsor_name":"Merck Sharp & Dohme LLC","has_results":true},{"nct_id":"NCT02405520","title":"Safety and Immunogenicity Study of the Recombinant Human Papillomavirus Virus Type 6/11 Bivalent Vaccine","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":145,"lead_sponsor_name":"Jun Zhang","has_results":false},{"nct_id":"NCT03981822","title":"A Placebo-Controlled Study Using VP-102 in the Treatment of External Genital Warts","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":105,"lead_sponsor_name":"Verrica Pharmaceuticals Inc.","has_results":true},{"nct_id":"NCT03158480","title":"Safety and Efficacy of Immune Therapy for Condyloma","phase":"NA","overall_status":"UNKNOWN","enrollment_count":80,"lead_sponsor_name":"Shenzhen Second People's Hospital","has_results":false},{"nct_id":"NCT06297187","title":"Cavitronic Ultrasonic Surgical Aspiration (CUSA) Women's Health Study","phase":"","overall_status":"COMPLETED","enrollment_count":56,"lead_sponsor_name":"Integra LifeSciences Corporation","has_results":false},{"nct_id":"NCT03813940","title":"Safety Study of Recombinant Human Papillomavirus Vaccine(6,11,16,18,31,33,45,52,58 Type)(E.Coli)","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Xiamen University","has_results":false},{"nct_id":"NCT01532102","title":"Safety and Efficacy Study of Topical AP611074 Gel to Treat Genital Warts","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":24,"lead_sponsor_name":"Anaconda Pharma","has_results":false},{"nct_id":"NCT03158974","title":"A Trial of a Botanical Drug Containing East Indian Sandalwood Oil (EISO) for the Treatment of External Genital Warts","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":12,"lead_sponsor_name":"ViroXis Corporation","has_results":false},{"nct_id":"NCT05087849","title":"Intralesional HPV Vaccine for Condylomata","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":2,"lead_sponsor_name":"University of California, San Francisco","has_results":true}],"total":16},"guidelines":[],"source":"Drug Landscape verified database"}